High-definition likelihood inference of genetic colocalization reveals protein biomarkers for human complex diseases
GigaScience · 21.01.2026 · 15
DOI: 10.1093/gigascience/giaf155 ↗Kurz gefasst
Fachartikel in der Zeitschrift GigaScience, online erschienen am 23.01.2026. Verfasst von Yuying Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77 Stockholm, Sweden. Hauptthemen laut MEDLINE: Biomarkers, Computational Biology. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program, Swedish Research Council.
Abstract (Originalsprache)
Background
Genetic colocalization analysis is essential for understanding the shared genetic basis between phenotypic traits. Such an analysis is particularly useful for identifying plasma proteins with potential as therapeutic targets or clinical biomarkers. Improvements to existing tools are needed for more accurate inference of potentially causal biomarkers.
Findings
We develop high-definition likelihood for colocalization inference (HDL-C), a method for genetic colocalization analysis. Based on simulations and observed rediscovery rates in real data analyses, we demonstrate that the HDL-C approach outperforms state-of-the-art methods, COLOC, SuSiE, and SharePro, in detecting genetic colocalization, thus enabling a more complete understanding of genetic connections at specific loci. Analyses of the top 50 protein–disease pairs identified by HDL-C in the male and female cohorts of the UK Biobank uncovered 40 previously validated drug-protein–disease combinations with approved drugs matching the phenotypes and 62 combinations with potential drug re-purposing opportunities. Additionally, we identified 63 novel protein–disease pairs that suggest promising candidates for future therapeutic interventions.
Conclusion
This research establishes a robust framework for detecting genetic colocalization signals, enabling the prioritization of disease-relevant protein targets and informing therapeutic development strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77 Stockholm, Sweden.
- Center for Intelligent Medicine Research, Greater Bay Area Institute of Precision Medicine (Guangzhou), Fudan University, 511458 Guangzhou, China.
- State Key Laboratory of Genetic Engineering, Center for Evolutionary Biology, School of Life Sciences, Fudan University, 200438 Shanghai, China.
- Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, 00014 Helsinki, Finland.
- Centre for Global Health Research, Usher Institute, University of Edinburgh, EH16 4UX Edinburgh, United Kingdom.
ORCID-Profile: Yuying Li, Ranran Zhai, Zhijian Yang, Ting Li, Yudi Pawitan, Xia Shen
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program
- Swedish Research Council
Zitieren
APA
Li, Y., Zhai, R., Yang, Z., Li, T., Pawitan, Y., & Shen, X. (2026). High-definition likelihood inference of genetic colocalization reveals protein biomarkers for human complex diseases. GigaScience, 15. https://doi.org/10.1093/gigascience/giaf155
Vancouver
Li Y, Zhai R, Yang Z, Li T, Pawitan Y, Shen X. High-definition likelihood inference of genetic colocalization reveals protein biomarkers for human complex diseases. GigaScience. 2026;15. doi:10.1093/gigascience/giaf155
BibTeX
@article{Li2026,
author = {Li, Yuying and Zhai, Ranran and Yang, Zhijian and Li, Ting and Pawitan, Yudi and Shen, Xia},
title = {High-definition likelihood inference of genetic colocalization reveals protein biomarkers for human complex diseases},
journal = {GigaScience},
year = {2026},
volume = {15},
doi = {10.1093/gigascience/giaf155}
}
EUVIMED